Close Menu

Middle East

Variantyx, a 2014 spinout from Tel Aviv University that is based in Framingham, Massachusetts, provides clinical genomic testing for screening and rare disease diagnostics.

In PLOS this week: single protein identification method, Vibrio cholerae sequences from spotted filter paper, and more.

The Israeli online genealogy company recently expanded its ancestry genetic testing offering to include health information.

In PNAS this week: tool to predict pathogenic gene pairs, analysis of bat evolution, and more.

Parker Institute for Cancer Immunotherapy will use Personalis' ImmunoID Next cancer immunogenomics platform to investigate biomarkers of response to immunotherapies in clinical trial participants.

The team sequenced more than 2,200 Saudi families to find the likely source of genetic disease in about 43 percent of cases.

Baylor Genetics will be King Faisal Specialist Hospital International's exclusive lab partner for all genetic testing and precision medicine applications.

In PLOS this week: exome sequencing ties PIK3C2A mutation to new Mendelian disorder, genetic profiles of Plasmodium species in Namibia, and more.

Genomic data for almost 300 ancient Eurasian horses points to lost equine lineages, horse relationships that reflect human interactions, and a recent loss in genetic diversity.

In PLOS this week: antibiotic resistance patterns in Escherichia coli, a dozen genetic loci tied to varicose vein risk, and more.

Pages

A German shepherd called Nala has had her genome sequenced.

A coronavirus serology test garners Emergency Use Authorization from the US Food and Drug Administration, but the Los Angeles Times asks: how will tests like that be used?

Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.

In Science this week: increased CD8 T cell density and increased IFN-gamma response may indicate metastatic prostate cancer patients who will respond to immune checkpoint blockade therapy.